Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Asset Utilization Ratio (2022 - 2026)

Lucid Diagnostics posted quarterly Asset Utilization Ratio of 0.14 for Q1 2026, up 6.27% year-on-year from 0.13 in Q1 2025, and up 38.19% on a QoQ basis from 0.1 in Q4 2025.

Lucid Diagnostics (LUCD) has 5 years of Asset Utilization Ratio data on file, last reported at 0.14 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 6.27% year-over-year to 0.14; the trailing twelve-month figure through Mar 2026 stood at 0.14 (up 6.27% YoY), and the FY2025 full-year result was 0.13, down 11.76% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.14, up from 0.1 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.16 in Q4 2024 and bottomed at 0.01 in Q4 2022.
  • The 5-year median for Asset Utilization Ratio is 0.1 (2024), against an average of 0.08.
  • The widest annual swing landed in 2023, when Asset Utilization Ratio jumped 654.41%; it then sank 38.01% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then surged by 654.41% to 0.08 in 2023, then surged by 103.17% to 0.16 in 2024, then tumbled by 38.01% to 0.1 in 2025, then soared by 38.19% to 0.14 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.14 (Q1 2026), 0.1 (Q4 2025), and 0.1 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 0.14

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.14
Dec 31, 2025 0.10
Sep 30, 2025 0.10
Jun 30, 2025 0.12
Mar 31, 2025 0.13
Dec 31, 2024 0.16
Sep 30, 2024 0.15
Jun 30, 2024 0.11
Mar 31, 2024 0.10
Dec 31, 2023 0.08
Sep 30, 2023 0.04
Jun 30, 2023 0.02
Mar 31, 2023 0.02
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01